X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-12-05 | ENTA | Capps Kathleen S. | See Remarks | S - Sale | $14.23 | -323 | 8,377 | -4% | -$4,596 | ||||||
2025-12-05 | ENTA | Trout Harry R. III | See Remarks | S - Sale | $14.23 | -542 | 16,348 | -3% | -$7,713 | ||||||
2025-12-05 | ENTA | Rottinghaus Scott T. | Chief Medical Officer | S - Sale | $14.23 | -798 | 21,792 | -4% | -$11,356 | ||||||
2025-12-05 | ENTA | Luu Brendan | Chief Business Officer | S - Sale | $14.23 | -1,394 | 38,329 | -4% | -$19,837 | ||||||
2025-12-05 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Officer | S - Sale | $14.23 | -2,106 | 30,620 | -6% | -$29,968 | ||||||
2025-12-05 | ENTA | Or Yat Sun | Chief Scientific Officer | S - Sale | $14.23 | -2,390 | 371,392 | -1% | -$34,010 | ||||||
2025-12-05 | ENTA | Luly Jay R. | Pres, CEO | S - Sale | $14.23 | -4,743 | 858,026 | -1% | -$67,493 | ||||||
2025-12-02 | ENTA | Capps Kathleen S. | See Remarks | S - Sale | $13.96 | -207 | 8,700 | -2% | -$2,890 | ||||||
2025-12-02 | ENTA | Trout Harry R. III | See Remarks | S - Sale | $13.96 | -380 | 16,890 | -2% | -$5,305 | ||||||
2025-02-12 | ENTA | Luly Jay R. | Pres, CEO | P - Purchase | $5.69 | +45,000 | 846,638 | +6% | +$256,050 | ||||||
2024-12-06 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Officer | S - Sale | $8.06 | -2,283 | 29,305 | -7% | -$18,401 | ||||||
2024-12-06 | ENTA | Luu Brendan | Chief Business Officer | S - Sale | $8.06 | -2,283 | 36,047 | -6% | -$18,401 | ||||||
2024-12-06 | ENTA | Rottinghaus Scott T. | Chief Medical Officer | S - Sale | $8.06 | -866 | 17,918 | -5% | -$6,980 | ||||||
2024-12-06 | ENTA | Or Yat Sun | Chief Scientific Officer | S - Sale | $8.06 | -2,591 | 369,109 | -1% | -$20,883 | ||||||
2024-12-06 | ENTA | Mellett Paul J | Chief Fin., Admin Officer | S - Sale | $8.06 | -2,591 | 91,710 | -3% | -$20,883 | ||||||
2024-12-06 | ENTA | Luly Jay R. | Pres, CEO | S - Sale | $8.06 | -5,142 | 801,638 | -1% | -$41,445 | ||||||
| DM | 2024-07-11 | ENTA | Rottinghaus Scott T. | Chief Medical Officer | S - Sale+OE | $15.97 | -11,945 | 21,717 | -35% | -$190,747 | |||||
2024-06-17 | ENTA | Kieffer Tara Lynn | Chief Product Strategy Officer | S - Sale | $12.33 | -7,266 | 32,341 | -18% | -$89,590 | ||||||
2023-12-13 | ENTA | Vance Terry | Dir | S - Sale | $9.12 | -15,295 | 5,800 | -73% | -$139,490 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |